| Issue Date | Title | Author(s) |
| 2016-05-18 | Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing | Cole, AJ; Dwight, T; Gill, AJ; Dickson, KA; Zhu, Y; Clarkson, A; Gard, GB; Maidens, J; Valmadre, S; Clifton-Bligh, R; Marsh, DJ |
| 2018-11 | Bayesian approach to determining penetrance of pathogenic SDH variants. | Benn, DE; Zhu, Y; Andrews, KA; Wilding, M; Duncan, EL; Dwight, T; Tothill, RW; Burgess, J; Crook, A; Gill, AJ; Hicks, RJ; Kim, E; Luxford, C; Marfan, H; Richardson, AL; Robinson, B; Schlosberg, A; Susman, R; Tacon, L; Trainer, A; Tucker, K; Maher, ER; Field, M; Clifton-Bligh, RJ |
| 2019-06-20 | Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: A cluster randomised trial protocol | Morrow, A; Hogden, E; Kang, YJ; Steinberg, J; Canfell, K; Solomon, MJ; Kench, JG; Gill, AJ; Shaw, T; Pachter, N; Parkinson, B; Wolfenden, L; Mitchell, G; Macrae, F; Tucker, K; Taylor, N |
| 2017-09-05 | Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency | Cole, AJ; Zhu, Y; Dwight, T; Yu, B; Dickson, KA; Gard, GB; Maidens, J; Valmadre, S; Gill, AJ; Clifton-Bligh, R; Marsh, DJ |
| 2016-03-23 | Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity | Glastras, SJ; Chen, H; McGrath, RT; Zaky, AA; Gill, AJ; Pollock, CA; Saad, S |
| 2017-08 | Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. | Najdawi, F; Crook, A; Maidens, J; McEvoy, C; Fellowes, A; Pickett, J; Ho, M; Nevell, D; McIlroy, K; Sheen, A; Sioson, L; Ahadi, M; Turchini, J; Clarkson, A; Hogg, R; Valmadre, S; Gard, G; Dooley, SJ; Scott, RJ; Fox, SB; Field, M; Gill, AJ |
| 2016-01-01 | Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma | Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ |
| 2020-05 | NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases. | Chou, A; Fraser, T; Ahadi, M; Fuchs, T; Sioson, L; Clarkson, A; Sheen, A; Singh, N; Corless, CL; Gill, AJ |
| 2019-01-01 | Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) parathyroid tumors demonstrate distinctive morphologic features | Gill, AJ; Lim, G; Cheung, VKY; Andrici, J; Perry-Keene, JL; Paik, J; Sioson, L; Clarkson, A; Sheen, A; Luxford, C; Elston, MS; Meyer-Rochow, GY; Nano, MT; Kruijff, S; Engelsman, AF; Sywak, M; Sidhu, SB; Delbridge, LW; Robinson, BG; Marsh, DJ; Toon, CW; Chou, A; Clifton-Bligh, RJ |
| 2016-03 | Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. | Flynn, A; Dwight, T; Harris, J; Benn, D; Zhou, L; Hogg, A; Catchpoole, D; James, P; Duncan, EL; Trainer, A; Gill, AJ; Clifton-Bligh, R; Hicks, RJ; Tothill, RW |
| 2018-11-30 | ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. | Pinho, AV; Van Bulck, M; Chantrill, L; Arshi, M; Sklyarova, T; Herrmann, D; Vennin, C; Gallego-Ortega, D; Mawson, A; Giry-Laterriere, M; Magenau, A; Leuckx, G; Baeyens, L; Gill, AJ; Phillips, P; Timpson, P; Biankin, AV; Wu, J; Rooman, I |
| 2018-11-01 | ROBO2 is a Stroma Suppressor Gene in the Pancreas Through Regulation of TGF-beta | Pinho, AV; Bulck, MV; Chantrill, L; Arshi, M; Sklyarova, T; Herrmann, D; Vennin, C; Gallego-Ortega, D; Mawson, A; Giry-Laterriere, M; Magenau, A; Baeyens, L; Gill, AJ; Phillips, P; Timpson, P; Biankin, AV; Wu, J; Rooman, I |
| 2017-02 | Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target. | Selinger, CI; Li, BT; Pavlakis, N; Links, M; Gill, AJ; Lee, A; Clarke, S; Tran, TN; Lum, T; Yip, PY; Horvath, L; Yu, B; Kohonen-Corish, MRJ; O'Toole, SA; Cooper, WA |
| 2016-12-15 | The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer | Dickson, K-A; Cole, AJ; Gill, AJ; Clarkson, A; Gard, GB; Chou, A; Kennedy, CJ; Henderson, BR; Fereday, S; Traficante, N; Alsop, K; Bowtell, DD; deFazio, A; Clifton-Bligh, R; Marsh, DJ |
| 2017-04-05 | Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. | Vennin, C; Chin, VT; Warren, SC; Lucas, MC; Herrmann, D; Magenau, A; Melenec, P; Walters, SN; Del Monte-Nieto, G; Conway, JRW; Nobis, M; Allam, AH; McCloy, RA; Currey, N; Pinese, M; Boulghourjian, A; Zaratzian, A; Adam, AAS; Heu, C; Nagrial, AM; Chou, A; Steinmann, A; Drury, A; Froio, D; Giry-Laterriere, M; Harris, NLE; Phan, T; Jain, R; Weninger, W; McGhee, EJ; Whan, R; Johns, AL; Samra, JS; Chantrill, L; Gill, AJ; Kohonen-Corish, M; Harvey, RP; Biankin, AV; Australian Pancreatic Cancer Genome Initiative (APGI),; Evans, TRJ; Anderson, KI; Grey, ST; Ormandy, CJ; Gallego-Ortega, D; Wang, Y; Samuel, MS; Sansom, OJ; Burgess, A; Cox, TR; Morton, JP; Pajic, M; Timpson, P |
